Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Preusser

Showing results (261-270 of 527) with videos related to

Pageof 53
Sort By:
Histopathology|July 22, 2014
Amplification and overexpression of CMET is a common event in brain metastases of non-small cell lung cancerMatthias Preusser, Berthold Streubel, Anna S Berghoff, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 28, 2017
Glioma Survival Prediction with Combined Analysis of In Vivo <sup>11</sup>C-MET PET Features, Ex Vivo Features, and Patient Features by Supervised Machine LearningLászló Papp, Nina Pötsch, Marko Grahovac, et al.
Springerplus|February 13, 2015
Response to imatinib as a function of target kinase expression in recurrent glioblastomaMarco Ronald Hassler, Mariam Vedadinejad, Birgit Flechl, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 6, 2026
Lack of LAT1 and CD98hc Expression on Tumor Cells of Diffuse Glioma: Revisiting the Molecular Basis for Amino Acid PET Imaging and TheranosticsJan-Michael Werner, Erwin Tomasich, Maximilian J Mair, et al.
Blood|October 17, 2020
Incidence, risk factors, and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapyFlorian Moik, Wei-Shin Evelyn Chan, Sarah Wiedemann, et al.
Clinical Neuropathology|December 24, 2013
Clinical Neuropathology practice news 1-2014: pyrosequencing meets clinical and analytical performance criteria for routine testing of MGMT promoter methylation status in glioblastomaMatthias Preusser, Anna S Berghoff, Claudia Manzl, et al.
Clinical Neuropathology|November 3, 2015
KINFix--A formalin-free non-commercial fixative optimized for histological, immunohistochemical and molecular analyses of neurosurgical tissue specimensHarald Stefanits, Michal Bienkowski, Markus Galanski, et al.
European Radiology|June 15, 2016
Local image variance of 7 Tesla SWI is a new technique for preoperative characterization of diffusely infiltrating gliomas: correlation with tumour grade and IDH1 mutational statusGünther Grabner, Barbara Kiesel, Adelheid Wöhrer, et al.
Anticancer Research|March 14, 2013
Brain metastases of gastro-oesophageal cancer: evaluation of molecules with relevance for targeted therapiesMatthias Preusser, Anna S Berghoff, Aysegül Ilhan-Mutlu, et al.
Journal of Neurosurgery|October 28, 2017
Systematic histopathological analysis of different 5-aminolevulinic acid-induced fluorescence levels in newly diagnosed glioblastomasBarbara Kiesel, Mario Mischkulnig, Adelheid Woehrer, et al.
Pageof 53

Showing results (261-270 of 527) with videos related to

Sort By:
Pageof 53
Histopathology|July 22, 2014
Amplification and overexpression of CMET is a common event in brain metastases of non-small cell lung cancerMatthias Preusser, Berthold Streubel, Anna S Berghoff, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 28, 2017
Glioma Survival Prediction with Combined Analysis of In Vivo <sup>11</sup>C-MET PET Features, Ex Vivo Features, and Patient Features by Supervised Machine LearningLászló Papp, Nina Pötsch, Marko Grahovac, et al.
Springerplus|February 13, 2015
Response to imatinib as a function of target kinase expression in recurrent glioblastomaMarco Ronald Hassler, Mariam Vedadinejad, Birgit Flechl, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 6, 2026
Lack of LAT1 and CD98hc Expression on Tumor Cells of Diffuse Glioma: Revisiting the Molecular Basis for Amino Acid PET Imaging and TheranosticsJan-Michael Werner, Erwin Tomasich, Maximilian J Mair, et al.
Blood|October 17, 2020
Incidence, risk factors, and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapyFlorian Moik, Wei-Shin Evelyn Chan, Sarah Wiedemann, et al.
Clinical Neuropathology|December 24, 2013
Clinical Neuropathology practice news 1-2014: pyrosequencing meets clinical and analytical performance criteria for routine testing of MGMT promoter methylation status in glioblastomaMatthias Preusser, Anna S Berghoff, Claudia Manzl, et al.
Clinical Neuropathology|November 3, 2015
KINFix--A formalin-free non-commercial fixative optimized for histological, immunohistochemical and molecular analyses of neurosurgical tissue specimensHarald Stefanits, Michal Bienkowski, Markus Galanski, et al.
European Radiology|June 15, 2016
Local image variance of 7 Tesla SWI is a new technique for preoperative characterization of diffusely infiltrating gliomas: correlation with tumour grade and IDH1 mutational statusGünther Grabner, Barbara Kiesel, Adelheid Wöhrer, et al.
Anticancer Research|March 14, 2013
Brain metastases of gastro-oesophageal cancer: evaluation of molecules with relevance for targeted therapiesMatthias Preusser, Anna S Berghoff, Aysegül Ilhan-Mutlu, et al.
Journal of Neurosurgery|October 28, 2017
Systematic histopathological analysis of different 5-aminolevulinic acid-induced fluorescence levels in newly diagnosed glioblastomasBarbara Kiesel, Mario Mischkulnig, Adelheid Woehrer, et al.
Pageof 53